Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theravex Tissue Care Plus With Xenograft in Internal Sinus Lifting
NCT07627633Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Randomised, double-blind trial of Theravex Tissue Care Plus in edentulism (2 arms), sponsored by Ain Shams University. Primary endpoint: Implant Stability Quotient at 3 months. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
Theravex Tissue Care Plus
03
Conditions
edentulism
Beyond the preview
Go deeper on NCT07627633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07627633.